Trademark: 97398433
Word
ACCREDO ONE ADHERENCE
Status Date
Tuesday, December 12, 2023
Filing Date
Friday, May 6, 2022
Published for Opposition
Tuesday, April 18, 2023
36 Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services; advisory services and consultancy regarding healthcare benefits and pharmacy benefits concerning insurance and finance; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits concerning insurance and finance; Medicare prescription coverage plans services, namely, providing insurance underwriting and claims administration of Medicare prescription drug plans for qualified beneficiaries; Insurance administration of pharmacy benefit plans; pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify potential cost savings and for clinical benefits
35 Drug utilization review services and prescription drug cost management services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and market analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the fields of pharmacy benefit management to be used by member populations of pharmacy benefit management clients; cost management for prescription drug benefit plans of others in the field of pharmaceuticals; business services, namely, prescription drug cost management services
44 Advisory services and consultancy regarding healthcare; healthcare services, complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions; providing medical information and medical analysis services for diagnostic and treatment purposes in the fields of healthcare, pharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers; Prescription refill reminder services; remote monitoring of medical data indicative of the health and condition of an individual and groups of individuals for medical diagnosis and treatment purposes, namely, patient medication dosage, usage and adherence; providing healthcare and medication information to patients by telephone; medical services, namely, providing patient education in the nature of providing information to patients in the field of medication administration, storage, adherence, and side effects and medical consultations over the telephone; telemedicine services; providing information to patients in the field of administering medications
42 Providing a website featuring technology that enables users to monitor prescription medication adherence
Dec 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 12, 2023
Sou Extension 1 Granted
Dec 12, 2023
Sou Extension 1 Filed
Dec 12, 2023
Sou Teas Extension Received
Jun 13, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 18, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 18, 2023
Published For Opposition
Mar 29, 2023
Notification Of Notice Of Publication E-Mailed
Mar 16, 2023
Approved For Pub - Principal Register
Mar 16, 2023
Examiner's Amendment Entered
Mar 16, 2023
Notification Of Examiners Amendment E-Mailed
Mar 16, 2023
Examiners Amendment E-Mailed
Mar 16, 2023
Examiners Amendment -Written
Feb 28, 2023
Teas/Email Correspondence Entered
Feb 27, 2023
Correspondence Received In Law Office
Feb 27, 2023
Teas Response To Office Action Received
Aug 27, 2022
Notification Of Non-Final Action E-Mailed
Aug 27, 2022
Non-Final Action E-Mailed
Aug 27, 2022
Non-Final Action Written
Aug 19, 2022
Assigned To Examiner
May 10, 2022
New Application Office Supplied Data Entered
May 10, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
